Skip to main content

Day: March 2, 2021

Streamline Health® Expands Credit Facility with Bridge Bank

Atlanta, GA, March 02, 2021 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it has expanded its existing relationship with Bridge Bank on its credit facility.A key element of the expansion is the transition to a “recurring revenue line of credit” in which Streamline has increased its total capacity to $3 million and improved its total pricing of the credit facility. The new credit facility has a two-year term, during which Streamline may borrow based upon three months trailing recurring revenue. The financial covenants will be recurring revenue and Adjusted EBITDA, which are targeted based upon Streamline’s annual plan as approved by the Board of Directors.Streamline...

Continue reading

Eloro Resources Announces C$12,900,000 Bought Deal Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, March 02, 2021 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (the “Company” or “Eloro”) (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) is pleased to announce that it has entered into an agreement with Haywood Securities Inc. to act as co-lead underwriter and sole bookrunner, and Cormark Securities Inc. to act as co-lead underwriter (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 3,440,000 units (the “Units”) at a price of C$3.75 per Unit (the “Issue Price”) for gross proceeds to the Company of C$12,900,000 (the “Offering”).Each Unit will consist of one common share (a “Common Share”) in...

Continue reading

Uniti Group Inc. to Present at the Deutsche Bank 29th Annual Media, Internet & Telecom Conference

LITTLE ROCK, Ark., March 02, 2021 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Executive Vice President, Chief Financial Officer and Treasurer, Mark Wallace, and President, Wholesale and Strategic Accounts, Greg Ortyl, are scheduled to participate at the Deutsche Bank 29th Annual Media, Internet & Telecom Conference. The presentation is scheduled for 3:00 PM ET on March 8, 2021.You may access a live webcast of the virtual event on Uniti’s website at www.uniti.com under the Investors tab. The webcast will be available for replay for a limited time on Uniti’s website following the presentation.ABOUT UNITIUniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of...

Continue reading

Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance

SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and the full year ended December 31, 2020. Highlights include:Revenue of $98.4 million for the fourth quarter and $284.1 million for the full year of 2020, representing 173.5% and 98.5% increases, respectively, over the corresponding periods of 2019;Expanded our IP Portfolio with a third U.S. patent granted for CleanCap® technology for the co-transcriptional capping of messenger RNA (mRNA);   Expanded nucleic acid production capacity via infrastructure investment and manufacturing process improvements, including substantial expansion of our GMP capacity and plasmid DNA capabilities;...

Continue reading

Ambarella, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results

SANTA CLARA, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Ambarella, Inc. (Nasdaq: AMBA), an AI vision silicon company, today announced financial results for its fourth quarter of fiscal year 2021 ending January 31, 2021.Revenue for the fourth quarter of fiscal 2021 was $62.1 million, up 9% from $57.2 million in the same period in fiscal 2020. For the fiscal year ending January 31, 2021, revenue was $223.0 million, down 3% from $228.7 million for the fiscal year ending January 31, 2020.Gross margin under U.S. generally accepted accounting principles (GAAP) for the fourth quarter of fiscal 2021 was 60.8%, compared with 58.2% for the same period in fiscal 2020. For the fiscal year ending January 31, 2021, GAAP gross margin was 60.8%, compared with 58.0% for the fiscal year ending January 31, 2020.GAAP net loss for the fourth quarter of...

Continue reading

Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress

Advanced and Expanded Portfolio of RAS(ON) Inhibitors; Two Assets Entered IND-Enabling DevelopmentContinued Progress in Development of RAS Companion Inhibitors to Support Targeted Combination TherapiesStrengthened Balance Sheet – Completed Financing Raising $281 Million in Net ProceedsREDWOOD CITY, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, today announced its financial results for the fourth quarter and year ended December 31, 2020, and provided a corporate update.“Revolution Medicines has achieved multiple significant milestones, furthering the company’s position as a leading precision oncology company dedicated to the development of innovative targeted...

Continue reading

Conifex Reports 2020 Year-end and Fourth Quarter Results and Resumption of Power Operations

VANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) — Conifex Timber Inc. (“Conifex”, “we” or “us”) (TSX: CFF) today reported results for the fourth quarter and year ended December 31, 2020. Adjusted EBITDA* from continuing operations was $6.8 million for the quarter, which reflected continued positive results from lumber operations, offset partially by the power plant disruption in early December. Power plant operations resumed at full capacity in late February following a concerted effort to procure and install new replacement equipment despite Covid-19 related challenges with global logistics and employee mobility.“Following a challenging start to 2020, we safely and successfully resumed operations at the Mackenzie sawmill and benefited from the unprecedented strength in lumber markets in the second half of the year.”...

Continue reading

Grocery Outlet Holding Corp. Announces Fourth Quarter and Fiscal 2020 Financial Results

EMERYVILLE, Calif., March 02, 2021 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”) today announced financial results for the fourth quarter and full fiscal year 2020 ended January 2, 2021, both of which contained one additional week (“53rd week”) versus the comparable prior periods.Highlights for Fourth Quarter Fiscal 2020 as compared to the Fourth Quarter Fiscal 2019:Net sales increased by 23.1% to $806.8 million, which includes $53.3 million from the 53rd week.Comparable store sales increased by 7.9% on a 13-week basis over a 5.1% increase in the same period last year.The Company opened eight new stores ending the quarter with 380 stores in six states.Net income increased 146.8% to $24.3 million, or $0.24 per diluted share.Adjusted net income(1)...

Continue reading

Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results

TORONTO, March 02, 2021 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today reported financial results for the fourth quarter and full year ended December 31, 2020.Change in Presentation CurrencyEffective December 31, 2020, Profound changed its presentation currency from the Canadian dollar to the United States dollar. The Company believes that changing its presentation currency to U.S. dollars will result in more relevant and reliable information for its financial statement users, and will more accurately reflect the results of its operations.For the period ended September 30, 2020 and for all prior periods, Profound presented its financial...

Continue reading

Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16

FORT LAUDERDALE, Fla., March 02, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its fourth quarter and full year 2020 financial results on Tuesday, March 16, 2021, after the market close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide updates on recent corporate developments.A replay of the webcast will be archived on the Motus GI website, www.motusgi.com, for 90 days following the event.About Motus GIMotus GI Holdings, Inc. is a medical technology company, with subsidiaries...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.